Taiwan FDA registration 53f6731f4b58d092b7ac4bdfd0a4e673
Suledine - HIV
TW: 速樂定-HIV
Taiwan·Risk Class 3·FUJIREBIO, Inc., Hachioji Facility·Registered Sep 09, 2005 – Aug 01, 2018CancelledRegistration details
- Analysis ID
- 53f6731f4b58d092b7ac4bdfd0a4e673
- Customs Code
- DHA00601228008
Company information
- Manufacturer
- FUJIREBIO, Inc., Hachioji Facility
- Manufacturer Country
- Japan
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Intended Use
- Particle agglutination test for human immunodeficiency virus antibodies (anti-HIV) for screening.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Import Information
- import
Dates and status
- Registration Date
- Sep 09, 2005
- Expiry Date
- Aug 01, 2018
- Cancellation Date
- Jun 16, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Suledine - HIV in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 53f6731f4b58d092b7ac4bdfd0a4e673 and manufactured by FUJIREBIO, Inc., Hachioji Facility. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices